PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

PCI Pharma Services, a Philadelphia-based biotherapy-focused contract development and manufacturing organization, has secured an investment co-led by Bain Capital and existing backer Kohlberg.

Bain and Kohlberg are leading an investment round in PCI Pharma Services, valuing it at $10 billion, as AI accelerates drug ...

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

A dispute over the Federal Reserve's renovation of its headquarters could provide the pretext to attempt the removal of Fed chief Jerome Powell over interest-rate disagreements. The buyout industry's ...

Crypto is continuing its bull run at the start of what has been dubbed "Crypto Week" in Washington, where the House of Representatives will consider three bills with the potential to overhaul U.S.

Pharmaceutical air logistics is undergoing a structural transformation, as mergers, infrastructure investments, and real-time ...

Explore the latest pharmaceutical trends and predictions for 2025 from an incoming CEO's perspective. Stay ahead of the curve and prepare your organisation for the future.

Chief executive officer and co-founder of Amryt Pharma, Dr Joe Wiley, added: “ Chiesi is aligned with Amryt’s commitment and passion, and I believe Chiesi will further maximise the value of ...